Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M

Akers Biosciences reports 2023 executive compensation

By ExecPay News

Published: 1 hours ago

Akers Biosciences reported fiscal year 2023 executive compensation information on November 1, 2024.
In 2023, four executives at Akers Biosciences received on average a compensation package of $1.1M, a 337% increase compared to previous year.
Average pay of disclosed executives at Akers Biosciences
Christopher Chapman, Chief Medical Officer, received $2.9M in total, which increased by 1,002% compared to 2022. 77% of Chapman's compensation, or $2.2M, was in option awards. Chapman also received $200K in bonus, $465K in salary, as well as $1.1K in other compensation.
Adam Kaplin, Chief Scientific Officer, received a compensation package of $594K, which increased by 68% compared to previous year. 42% of the compensation package, or $250K, was in salary.
Paul Rivard, Chief Legal Officer, earned $578K in 2023, a 207% increase compared to previous year.
Ian Rhodes, Chief Financial Officer, received $162K in 2023, which is the same as previous year.

Related executives

Christopher Chapman

Akers Biosciences

Chief Medical Officer

Adam Kaplin

Akers Biosciences

Chief Scientific Officer

Ian Rhodes

Akers Biosciences

Chief Financial Officer

Paul Rivard

Akers Biosciences

Chief Legal Officer

You may also like

Source: SEC filing on November 1, 2024.